Aclaris Therapeutics, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (30)

Latest Posts

About This Stock More About This Stock
Aclaris Therapeutics - Chart Of The Day
Article By: Jim Van Meerten
Monday, October 3, 2016 4:48 PM EDT
The Chart of the Day belongs to Aclaris Therapeutics.
In this article: ACRS
Read
U.S. IPOs Lacked Luster In 2015: Will 2016 Turn The Tables?
Article By: Zacks Investment Research
Sunday, January 10, 2016 6:19 PM EDT
U.S. Initial Public Offerings (IPOs) were a major disappointment in 2015. According to Renaissance Capital, 170 IPOs raised only $30 billion (275 in 2014), which is the lowest since 2009.
In this article: BABA, MXPT, FIT, ACRS, FDC
Read
Best IPOs Of 2015
Article By: Zacks Investment Research
Tuesday, December 29, 2015 6:08 AM EDT
This past year did not see any record-breaking IPO performances like 2014’s historic market debut of Alibaba Group Holdings Ltd. – it was the largest IPO ever – which raised $25 billion.
In this article: SHAK, MCRB, ACRS, COLL, AVGR
Read
Aclaris Therapeutics IPO: Consider Holding Off
Article By: Don Dion
Tuesday, October 6, 2015 9:29 PM EDT
Aclaris Therapeutics Inc. (ACRS) expects to raise $75 million in its upcoming IPO. ACRS filed for the IPO on August 17, 2015.
In this article: ACRS
Read
Aclaris Could Be A Sleeper
Article By: IPO Candy
Monday, October 5, 2015 11:57 AM EDT
As a stab I'd say that the Aclaris shares might properly trade at a value that reflects 1/2 of the near-term market opportunity or about $600-700M or $30-35/share.
In this article: ACRS
Read

PARTNER HEADLINES

Latest Tweets for $ACRS

No tweets yet!